Performance of machine-learning scoring functions in structure-based virtual screening.

Cited by (365)

Items 101–200 of 365

1. Advanced AI and ML frameworks for transforming drug discovery and optimization: With innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine
   Subiya Ambreen, Mohammad Umar, Aaisha Noor, Himangini Jain, Ruhi Ali · 2024 · European Journal of Medicinal Chemistry
2. Artificial intelligence for small molecule anticancer drug discovery
   Lihui Duo, Yu Liu, Jianfeng Ren, Bencan Tang, Jonathan D. Hirst · 2024 · Expert Opinion on Drug Discovery
3. Docking strategies for predicting protein-ligand interactions and their application to structure-based drug design
   Zhiwei Ma, Abeeb Ajibade, Xiaoqin Zou · 2024 · Communications in Information and Systems
4. Deep-learning-based target screening and similarity search for the predicted inhibitors of the pathways in Parkinson's disease
   Abbas Khan, Aman Chandra Kaushik, Syed Shujait Ali, Nisar Ahmad, Dong‐Qing Wei · 2019 · RSC Advances
5. Limitations and future challenges of computer-aided drug design methods
   Ashish Harish Shah, Manav Jain · 2022 · Elsevier eBooks
6. Accuracy or novelty: what can we gain from target-specific machine-learning-based scoring functions in virtual screening?
   Chao Shen, Gaoqi Weng, Xujun Zhang, Elaine Lai‐Han Leung, Xiaojun Yao, Jinping Pang, Xin Chai, Dan Li, Ercheng Wang, Dongsheng Cao et al. · 2021 · Briefings in Bioinformatics
7. On the Value of Using 3D Shape and Electrostatic Similarities in Deep Generative Methods
   Giovanni Bolcato, Esther Heid, Jonas Boström · 2022 · Journal of Chemical Information and Modeling
8. High-throughput virtual laboratory for drug discovery using massive datasets
   Jens Gläser, Josh V. Vermaas, David O. Williams Rogers, Jeff Larkin, Scott LeGrand, Swen Boehm, Matthew B. Baker, Aaron Scheinberg, Andreas F. Tillack, Mathialakan Thavappiragasam et al. · 2021 · The International Journal of High Performance Computing Applications
9. Artificial Intelligence-Guided De Novo Molecular Design Targeting COVID-19
   Srilok Srinivasan, Rohit Batra, Henry Chan, Ganesh Kamath, Mathew J. Cherukara, Subramanian K. R. S. Sankaranarayanan · 2021 · ACS Omega
10. DockingApp RF: A State-of-the-Art Novel Scoring Function for Molecular Docking in a User-Friendly Interface to AutoDock Vina
    Gabriele Macari, Daniele Toti, Andrea Pasquadibisceglie, Fabio Polticelli · 2020 · International Journal of Molecular Sciences
11. The impact of cross-docked poses on performance of machine learning classifier for protein–ligand binding pose prediction
    Chao Shen, Xueping Hu, Junbo Gao, Xujun Zhang, Haiyang Zhong, Zhe Wang, Lei Xu, Yu Kang, Dongsheng Cao, Tingjun Hou · 2021 · Journal of Cheminformatics
12. Supervised machine learning of ultracold atoms with speckle disorder
    Sebastiano Pilati, P. Pieri · 2019 · Scientific Reports
13. Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae
    Nousheen Parvaiz, Faisal Ahmad, Wenbo Yu, Alexander D. MacKerell, Syed Sikander Azam · 2021 · PLoS ONE
14. SMMPPI: a machine learning-based approach for prediction of modulators of protein–protein interactions and its application for identification of novel inhibitors for RBD:hACE2 interactions in SARS-CoV-2
    Priya Gupta, Debasisa Mohanty · 2021 · Briefings in Bioinformatics
15. Past, Present, and Future of Molecular Docking
    Thuluz Meza‐Menchaca, Claudia Janeth Juárez-Portilla, Rossana Citlali Zepeda · 2020 · IntechOpen eBooks
16. Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity
    Mohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, Araz Ghanbarpour, Mohammad Ali Faramarzi, Latifeh Navidpour · 2023 · Bioorganic Chemistry
17. Structural interaction fingerprints and machine learning for predicting and explaining binding of small molecule ligands to RNA
    Natalia A. Szulc, Zuzanna Mackiewicz, Janusz Marek Bujnicki, Filip Stefaniak · 2023 · Briefings in Bioinformatics
18. Advances in machine intelligence‐driven virtual screening approaches for big‐data
    Neeraj Kumar, Vishal Acharya · 2023 · Medicinal Research Reviews
19. Towards accurate high-throughput ligand affinity prediction by exploiting structural ensembles, docking metrics and ligand similarity
    Melanie Schneider, Jean-Luc Pons, William Bourguet, Gilles Labesse · 2019 · Bioinformatics
20. EXSCALATE: An Extreme-Scale Virtual Screening Platform for Drug Discovery Targeting Polypharmacology to Fight SARS-CoV-2
    Davide Gadioli, Emanuele Vitali, Federico Ficarelli, Chiara Latini, Candida Manelfi, Carmine Talarico, Cristina Silvano, Carlo Cavazzoni, Gianluca Palermo, Andrea R. Beccari · 2022 · IEEE Transactions on Emerging Topics in Computing
21. FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening
    Zhou, Hongyi, Cao, Hongnan, Skolnick, Jeffrey · 2021 · Journal of Chemical Information and Modeling
22. Lin_F9: A Linear Empirical Scoring Function for Protein–Ligand Docking
    Chao Yang, Yingkai Zhang · 2021 · Journal of Chemical Information and Modeling
23. The Impact of Supervised Learning Methods in Ultralarge High-Throughput Docking
    Claudio N. Cavasotto, Juan I. Di Filippo · 2023 · Journal of Chemical Information and Modeling
24. Machine Learning Classification Models to Improve the Docking‐based Screening: A Case of PI3K‐Tankyrase Inhibitors
    Vladimir P. Berishvili, Andrew E. Voronkov, Eugene V. Radchenko, Vladimir A. Palyulin · 2018 · Molecular Informatics
25. Comprehensive evaluation of the MM-GBSA method on bromodomain-inhibitor sets
    Süleyman Selim Çınaroğlu, Emel Timuçin · 2019 · Briefings in Bioinformatics
26. SXGBsite: Prediction of Protein–Ligand Binding Sites Using Sequence Information and Extreme Gradient Boosting
    Ziqi Zhao, Yonghong Xu, Yong Zhao · 2019 · Genes
27. Modern Tools and Techniques in Computer-Aided Drug Design
    Tamanna Anwar, Pawan Kumar, Asad Ullah Khan · 2021 · Elsevier eBooks
28. Is high performance computing a requirement for novel drug discovery and how will this impact academic efforts?
    Savíns Puertas Martín, Antonio Jesús Banegas‐Luna, María Paredes-Ramos, Juana L. Redondo, Pilar M. Ortigosa, Ol’ha O. Brovarets’, Horacio Pérez‐Sánchez · 2020 · Expert Opinion on Drug Discovery
29. CRDS: Consensus Reverse Docking System for target fishing
    Aeri Lee, Dongsup Kim · 2019 · Bioinformatics
30. Protein language models are performant in structure-free virtual screening
    Hilbert Yuen In Lam, Jia Sheng Guan, Xing Er Ong, Robbe Pincket, Yuguang Mu · 2024 · Briefings in Bioinformatics
31. Guiding Conventional Protein–Ligand Docking Software with Convolutional Neural Networks
    Huaipan Jiang, Mengran Fan, Jian Wang, Anup Sarma, Shruti Mohanty, Nikolay V. Dokholyan, Mehrdad Mahdavi, Mahmut Kandemir · 2020 · Journal of Chemical Information and Modeling
32. Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors
    Alexander M. Andrianov, Grigory I. Nikolaev, Nikita A. Shuldov, Ivan P. Bosko, Arseny I. Anischenko, Alexander V. Tuzikov · 2021 · Journal of Biomolecular Structure and Dynamics
33. In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach
    Muthu Kumar Thirunavukkarasu, Utid Suriya, Thanyada Rungrotmongkol, Ramanathan Karuppasamy · 2021 · Pharmaceutics
34. Recent advances in computational and experimental protein-ligand affinity determination techniques
    Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas · 2024 · Expert Opinion on Drug Discovery
35. Improving the binding affinity estimations of protein–ligand complexes using machine-learning facilitated force field method
    Anjali Soni, Ruchika Bhat, Bhyravabhotla Jayaram · 2020 · Journal of Computer-Aided Molecular Design
36. Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development
    Chia‐Ju Hsieh, Sam G. Giannakoulias, E. James Petersson, Robert H. Mach · 2023 · Pharmaceuticals
37. In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
    Agostinho Lemos, Rita Melo, António J. Preto, José Guilherme de Almeida, Irina Sousa Moreira, M. Natália D. S. Cordeiro · 2018 · Current Neuropharmacology
38. Beware of Simple Methods for Structure-Based Virtual Screening: The Critical Importance of Broader Comparisons
    Viet‐Khoa Tran‐Nguyen, Pedro J. Ballester · 2023 · Journal of Chemical Information and Modeling
39. Selection of protein conformations for structure-based polypharmacology studies
    Luca Pinzi, Fabiana Caporuscio, Giulio Rastelli · 2018 · Drug Discovery Today
40. Advances in machine-learning approaches to RNA-targeted drug design
    Yuanzhe Zhou, Shi‐Jie Chen · 2024 · Artificial Intelligence Chemistry
41. Applying Machine Learning to Ultrafast Shape Recognition in Ligand-Based Virtual Screening
    Etienne Bonanno, Jean-Paul Ebejer · 2020 · Frontiers in Pharmacology
42. Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
    A. Kingdon, L. Alderwick · 2021 · Computational and Structural Biotechnology Journal
43. Ligand Binding Prediction Using Protein Structure Graphs and Residual Graph Attention Networks
    Mohit Kumar Pandey, Mariia Radaeva, Hazem Mslati, Olivia Garland, Michael Fernández, Martin Ester, Artem R Cherkasov · 2022 · Molecules
44. Improving drug-target affinity prediction via feature fusion and knowledge distillation
    Ruiqiang Lu, Jun Wang, Pengyong Li, Yuquan Li, Shuoyan Tan, Yiting Pan, Huanxiang Liu, Peng Gao, Guotong Xie, Xiaojun Yao · 2023 · Briefings in Bioinformatics
45. AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors
    Domiziana Cecchini, AkshatKumar Nigam, Ming Tang, Joana Reis, Matt Koop, Andrea Gottinger, Callum Robert Nicoll, Yao Wang, Abhilash Jayaraj, Suleyman Selim Cinaroglu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
46. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents
    Kushagra Kashyap, Mohammad Imran Siddiqi · 2021 · Molecular Diversity
47. Current trends on the application of artificial intelligence in medical sciences
    Aisha Mousa Mashraqi · 2022 · Bioinformation
48. Inactive-enriched machine-learning models exploiting patent data improve structure-based virtual screening for PDL1 dimerizers
    Pablo Gómez-Sacristán, Saw Simeon, Viet‐Khoa Tran‐Nguyen, Sachin P. Patil, Pedro J. Ballester · 2024 · Journal of Advanced Research
49. Comparative Assessment of Pose Prediction Accuracy in RNA–Ligand Docking
    Rupesh Agarwal, Rajitha Rajeshwar T., Jeremy C. Smith · 2023 · Journal of Chemical Information and Modeling
50. Strategies of Virtual Screening in Medicinal Chemistry
    Giovanna Ilaria Passeri, Daniela Trisciuzzi, Domenico Alberga, Lydia Siragusa, Francesco Leonetti, Giuseppe Felice Mangiatordi, Orazio Nicolotti · 2017 · International Journal of Quantitative Structure-Property Relationships
51. Shape-Restrained Modeling of Protein–Small-Molecule Complexes with High Ambiguity Driven DOCKing
    Panagiotis I. Koukos, Manon F. Réau, Alexandre M. J. J. Bonvin · 2021 · Journal of Chemical Information and Modeling
52. Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases
    Christopher Fernandez‐Prada, Noélie Douanne, Aida Minguez-Menendez, Joan Pena, Luiza Guimarães Tunes, Douglas E. V. Pires, Rubens Lima do Monte‐Neto · 2019 · Elsevier eBooks
53. A Database for Large-Scale Docking and Experimental Results
    Brendan W. Hall, Tia A. Tummino, Khanh G. Tang, Olivier Mailhot, Mar Castanon, John J. Irwin, Brian K. Shoichet · 2025 · Journal of Chemical Information and Modeling
54. CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
    Oleksandra Herasymenko, Madhushika Silva, Abd Al‐Aziz A. Abu‐Saleh, Ayaz Ahmad, Jesus Antonio Alvarado-Huayhuaz, Oscar E. A. Arce, Roly J. Armstrong, C.H. Arrowsmith, Kelly E. R. Bachta, Hartmut Beck et al. · 2025 · Journal of Chemical Information and Modeling
55. Energetic contributions of amino acid residues and its cross‐talk to delineate ligand‐binding mechanism
    Sivakumar Prasanth Kumar, Chirag Patel, Rakesh Rawal, Himanshu Pandya · 2020 · Proteins Structure Function and Bioinformatics
56. Commonly used surfactants sodium dodecyl sulphate, cetylpyridinium chloride and sodium laureth sulphate and their effects on antioxidant defence system and oxidative stress indices in Cyprinus carpio L.: an integrated in silico and in vivo approach
    Ritwick Bhattacharya, Arnab Chatterjee, Soumendranath Chatterjee, Nimai Chandra Saha · 2022 · Environmental Science and Pollution Research
57. Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors
    Klaudia Caba, Viet‐Khoa Tran‐Nguyen, Taufiq Rahman, Pedro J. Ballester · 2024 · Journal of Cheminformatics
58. AI-Based Computational Methods in Early Drug Discovery and Post Market Drug Assessment: A Survey
    Flora Rajaei, Cristian Minoccheri, Emily M. Wittrup, Richard C. Wilson, Brian D. Athey, Gilbert S. Omenn, Kayvan Najarian · 2024 · IEEE Transactions on Computational Biology and Bioinformatics
59. Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer
    Priyanka Ramesh, Ramanathan Karuppasamy, Shanthi Veerappapillai · 2022 · Medical Oncology
60. HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery
    Alvaro Prat, Hisham Abdel Aty, Orestis Bastas, Gintautas Kamuntavičius, Tanya Paquet, Povilas Norvaišas, Piero Gasparotto, Roy Tal · 2024 · Journal of Chemical Information and Modeling
61. Tailoring Proteins to Re-Evolve Nature: A Short Review
    Angélica Jiménez-Rosales, Miriam V. Flores‐Merino · 2018 · Molecular Biotechnology
62. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces
    Natesh Singh, Ludovic Chaput, Bruno O. Villoutreix · 2020 · Journal of Chemical Information and Modeling
63. Expanding the boundaries of ligand–target modeling by exascale calculations
    Viacheslav Bolnykh, Giulia Rossetti, Ursula Röthlisberger, Paolo Carloni · 2021 · Wiley Interdisciplinary Reviews Computational Molecular Science
64. Effects of protein-protein interactions and ligand binding on the ion permeation in KCNQ1 potassium channel
    Horia Jalily Hasani, Aravindhan Ganesan, Marawan Ahmed, Khaled Barakat · 2018 · PLoS ONE
65. Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies
    María Daniela Santi, Florencia Arredondo, Diego Carvalho, Carolina Echeverry, Giselle Prunell, Mariana Andrea Peralta, José Luis Cabrera, Marı́a Gabriela Ortega, Eduardo Savio, Juan Andrés Abin‐Carriquiry · 2020 · European Journal of Medicinal Chemistry
66. Simulation and Machine Learning Methods for Ion-Channel Structure Determination, Mechanistic Studies and Drug Design
    Zhengdan Zhu, Zhenfeng Deng, Qinrui Wang, Yuhang Wang, Duo Zhang, Ruihan Xu, Lvjun Guo, Han Wen · 2022 · Frontiers in Pharmacology
67. Perspectives on current approaches to virtual screening in drug discovery
    Ingo Muegge, Jörg Bentzien, Yunhui Ge · 2024 · Expert Opinion on Drug Discovery
68. Virtual screening: hope, hype, and the fine line in between
    Hossam Nada, Nicholas A. Meanwell, Moustafa Tarek Gabr · 2025 · Expert Opinion on Drug Discovery
69. FeatureDock for protein-ligand docking guided by physicochemical feature-based local environment learning using transformer
    Mingyi Xue, Bojun Liu, Siqin Cao, Xuhui Huang · 2025 · npj Drug Discovery.
70. Nonadditivity in public and inhouse data: implications for drug design
    Dea Gogishvili, Eva Nittinger, Christian Margreitter, Christian Tyrchan · 2021 · Journal of Cheminformatics
71. The Impact of Data on Structure-Based Binding Affinity Predictions Using Deep Neural Networks
    Pierre-Yves Libouban, Samia Aci‐Sèche, José Carlos Gómez-Tamayo, Gary Tresadern, Pascal Bonnet · 2023 · International Journal of Molecular Sciences
72. Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein–Ligand Structures: Towards Per-Target Scoring Functions
    Francesco Pellicani, Diego Dal Ben, Andrea Perali, Sebastiano Pilati · 2023 · Molecules
73. Computational representations of protein–ligand interfaces for structure-based virtual screening
    Qin Tong, Zihao Zhu, Xiang Simon Wang, Jie Xia, Song Wu · 2021 · Expert Opinion on Drug Discovery
74. A Hybrid Structure-Based Machine Learning Approach for Predicting Kinase Inhibition by Small Molecules
    Changchang Liu, Peter S. Kutchukian, Nhan Duc Nguyen, Mohammed AlQuraishi, Peter Karl Sorger · 2023 · Journal of Chemical Information and Modeling
75. Toward a Computational Ecotoxicity Assay
    Natasha Kamerlin, Mickaël G. Delcey, Sergio Manzetti, David van der Spoel · 2020 · Journal of Chemical Information and Modeling
76. In silicoinvestigations of someCyperus rotunduscompounds as potential anti-inflammatory inhibitors of 5-LO and LTA4H enzymes
    Fares Fenanir, Abderrahmane Semmeq, Yacine Benguerba, Michaël Badawi, Marie-Antoinette Dziurla, Smain Amira, Hocine Laouer · 2021 · Journal of Biomolecular Structure and Dynamics
77. <scp>PrePCI</scp> : A structure‐ and chemical similarity‐informed database of predicted protein compound interactions
    Trudeau, Stephen J., Hwang, Howook, Mathur, Deepika, Begum, Kamrun, Petrey, Donald, Murray, Diana, Honig, Barry · 2023 · Protein Science
78. Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
    Estevam, Gabriella O, Linossi, Edmond, Rao, Jingyou, Macdonald, Christian B, Ravikumar, Ashraya, Chrispens, Karson M, Capra, John A, Coyote-Maestas, Willow, Pimentel, Harold, Collisson, Eric A et al. · 2025 · eLife
79. Collaborative Approach between Explainable Artificial Intelligence and Simplified Chemical Interactions to Explore Active Ligands for Cyclin-Dependent Kinase 2
    Tomomi Shimazaki, Masanori Tachikawa · 2022 · ACS Omega
80. Exploring new horizons: Empowering computer-assisted drug design with few-shot learning
    Sabrina Silva Mendonça, Arthur Ricardo Sousa Vitória, Telma Woerle de Lima, Arlindo Rodrigues Galvão Filho, Carolina Horta Andrade · 2023 · Artificial Intelligence in the Life Sciences
81. A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein–Protein Interfaces
    Natesh Singh, Bruno O. Villoutreix · 2022 · International Journal of Molecular Sciences
82. Toward generalizable structure‐based deep learning models for protein–ligand interaction prediction: Challenges and strategies
    Seokhyun Moon, Wonho Zhung, Woo Youn Kim · 2024 · Wiley Interdisciplinary Reviews Computational Molecular Science
83. Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of rheumatoid arthritis: Virtual screening to comprehensive in silico investigation
    Tasnia Nabi, Tanver Hasan Riyed, Akid Ornob · 2024 · PLoS ONE
84. PLHINT: A knowledge-driven computational approach based on the intermolecular H bond interactions at the protein-ligand interface from docking solutions
    Sivakumar Prasanth Kumar · 2017 · Journal of Molecular Graphics and Modelling
85. Virtual screening and zebrafish models in tandem, for drug discovery and development
    David Hernández-Silva, Francisca Alcaraz‐Pérez, Horacio Pérez‐Sánchez, María Luisa Cayuela · 2022 · Expert Opinion on Drug Discovery
86. Application of computational methods for class A GPCR Ligand discovery
    Gregory L. Szwabowski, Daniel L. Baker, Abby L. Parrill · 2023 · Journal of Molecular Graphics and Modelling
87. A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer
    HemaNandini Rajendran Krishnamoorthy, K. Ramanathan · 2023 · Medical Oncology
88. Application of ensemble learning for predicting GABAA receptor agonists
    Xiao Fu, Xiaoyu Ding, Yan Shi, Dingyan Wang, Yitian Wang, Chen Cui, Tingfei Zhu, Kaixian Chen, Ping Xiang, Xiaomin Luo · 2024 · Computers in Biology and Medicine
89. Recent Applications of Artificial Intelligence in Discovery of New Antibacterial Agents
    Youcef Bagdad, Maria A. Miteva · 2024 · Advances and Applications in Bioinformatics and Chemistry
90. An evaluation of combined strategies for improving the performance of molecular docking
    Siqi Xu, Li Wang, Xianchao Pan · 2021 · Journal of Bioinformatics and Computational Biology
91. nCoVDock2: a docking server to predict the binding modes between COVID-19 targets and its potential ligands
    Kai Liu, Xufeng Lu, Hang Shi, Xiaojun Xu, Ren Kong, Shan Chang · 2023 · Nucleic Acids Research
92. Co-guided Dual-channel Graph Neural Networks for the prediction of compound–protein interaction
    Zheyu Wu, Huifang Ma, Bin Deng, Zhixin Li, Liang Chang · 2024 · Applied Soft Computing
93. A Practical Guide to Computational Tools for Engineering Biocatalytic Properties
    Aitor Vega, Antoni Planas, Xevi Biarnés · 2025 · International Journal of Molecular Sciences
94. Identification of putative Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) dual inhibitors for triple-negative breast cancer therapy
    Priyanga Paranthaman, Shanthi Veerappapillai · 2025 · Journal of Biomolecular Structure and Dynamics
95. Structure-based virtual screening for PDL1 dimerizers: Evaluating generic scoring functions
    Viet‐Khoa Tran‐Nguyen, Saw Simeon, Muhammad Junaid, Pedro J. Ballester · 2022 · Current Research in Structural Biology
96. Discovery and Design of Radiopharmaceuticals by In silico Methods
    David Alan Winkler, Maryam Salahinejad, Fereshteh Shiri · 2022 · Current Radiopharmaceuticals
97. Autonome Entdeckung in den chemischen Wissenschaften, Teil I: Fortschritt
    Connor W. Coley, Natalie S. Eyke, Klavs F. Jensen · 2019 · Angewandte Chemie
98. Testing automatic methods to predict free binding energy of host–guest complexes in SAMPL7 challenge
    Dylan Sérillon, Carles Bó, Xavier Barril · 2021 · Journal of Computer-Aided Molecular Design
99. Guided structure-based ligand identification and design via artificial intelligence modeling
    Juan I. Di Filippo, Claudio N. Cavasotto · 2021 · Expert Opinion on Drug Discovery
100. Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual Screening
     Jean-Paul Ebejer, Paul W. Finn, Wing Ki Wong, Charlotte Mary Deane, Garrett M. Morris · 2019 · Journal of Chemical Information and Modeling